Global Oligonucleotide Synthesis Market Size, Status and Forecast 2024-2031

Report ID: 1013558 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Oligonucleotide Synthesis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Custom Oligonucleotides
        1.2.3 Pre-designed Oligonucleotides
    1.3 Market by Application
        1.3.1 Global Oligonucleotide Synthesis Market Share by End User: 2016 VS 2021 VS 2027
        1.3.2 Academic Research Institutes
        1.3.3 Pharmaceutical and Biotechnology Companies
        1.3.4 Diagnostic Laboratories
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Oligonucleotide Synthesis Market Perspective (2016-2027)
    2.2 Oligonucleotide Synthesis Growth Trends by Regions
        2.2.1 Oligonucleotide Synthesis Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Oligonucleotide Synthesis Historic Market Share by Regions (2016-2021)
        2.2.3 Oligonucleotide Synthesis Forecasted Market Size by Regions (2022-2027)
    2.3 Oligonucleotide Synthesis Industry Dynamic
        2.3.1 Oligonucleotide Synthesis Market Trends
        2.3.2 Oligonucleotide Synthesis Market Drivers
        2.3.3 Oligonucleotide Synthesis Market Challenges
        2.3.4 Oligonucleotide Synthesis Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Oligonucleotide Synthesis Players by Revenue
        3.1.1 Global Top Oligonucleotide Synthesis Players by Revenue (2016-2021)
        3.1.2 Global Oligonucleotide Synthesis Revenue Market Share by Players (2016-2021)
    3.2 Global Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Oligonucleotide Synthesis Revenue
    3.4 Global Oligonucleotide Synthesis Market Concentration Ratio
        3.4.1 Global Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotide Synthesis Revenue in 2020
    3.5 Oligonucleotide Synthesis Key Players Head office and Area Served
    3.6 Key Players Oligonucleotide Synthesis Product Solution and Service
    3.7 Date of Enter into Oligonucleotide Synthesis Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Oligonucleotide Synthesis Breakdown Data by Type
    4.1 Global Oligonucleotide Synthesis Historic Market Size by Type (2016-2021)
    4.2 Global Oligonucleotide Synthesis Forecasted Market Size by Type (2022-2027)

5 Oligonucleotide Synthesis Breakdown Data by End User
    5.1 Global Oligonucleotide Synthesis Historic Market Size by End User (2016-2021)
    5.2 Global Oligonucleotide Synthesis Forecasted Market Size by End User (2022-2027)

6 North America
    6.1 North America Oligonucleotide Synthesis Market Size (2016-2027)
    6.2 North America Oligonucleotide Synthesis Market Size by Type
        6.2.1 North America Oligonucleotide Synthesis Market Size by Type (2016-2021)
        6.2.2 North America Oligonucleotide Synthesis Market Size by Type (2022-2027)
        6.2.3 North America Oligonucleotide Synthesis Market Size by Type (2016-2027)
    6.3 North America Oligonucleotide Synthesis Market Size by End User
        6.3.1 North America Oligonucleotide Synthesis Market Size by End User (2016-2021)
        6.3.2 North America Oligonucleotide Synthesis Market Size by End User (2022-2027)
        6.3.3 North America Oligonucleotide Synthesis Market Size by End User (2016-2027)
    6.4 North America Oligonucleotide Synthesis Market Size by Country
        6.4.1 North America Oligonucleotide Synthesis Market Size by Country (2016-2021)
        6.4.2 North America Oligonucleotide Synthesis Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Oligonucleotide Synthesis Market Size (2016-2027)
    7.2 Europe Oligonucleotide Synthesis Market Size by Type
        7.2.1 Europe Oligonucleotide Synthesis Market Size by Type (2016-2021)
        7.2.2 Europe Oligonucleotide Synthesis Market Size by Type (2022-2027)
        7.2.3 Europe Oligonucleotide Synthesis Market Size by Type (2016-2027)
    7.3 Europe Oligonucleotide Synthesis Market Size by End User
        7.3.1 Europe Oligonucleotide Synthesis Market Size by End User (2016-2021)
        7.3.2 Europe Oligonucleotide Synthesis Market Size by End User (2022-2027)
        7.3.3 Europe Oligonucleotide Synthesis Market Size by End User (2016-2027)
    7.4 Europe Oligonucleotide Synthesis Market Size by Country
        7.4.1 Europe Oligonucleotide Synthesis Market Size by Country (2016-2021)
        7.4.2 Europe Oligonucleotide Synthesis Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Oligonucleotide Synthesis Market Size (2016-2027)
    8.2 Asia-Pacific Oligonucleotide Synthesis Market Size by Type
        8.2.1 Asia-Pacific Oligonucleotide Synthesis Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Oligonucleotide Synthesis Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Oligonucleotide Synthesis Market Size by Type (2016-2027)
    8.3 Asia-Pacific Oligonucleotide Synthesis Market Size by End User
        8.3.1 Asia-Pacific Oligonucleotide Synthesis Market Size by End User (2016-2021)
        8.3.2 Asia-Pacific Oligonucleotide Synthesis Market Size by End User (2022-2027)
        8.3.3 Asia-Pacific Oligonucleotide Synthesis Market Size by End User (2016-2027)
    8.4 Asia-Pacific Oligonucleotide Synthesis Market Size by Region
        8.4.1 Asia-Pacific Oligonucleotide Synthesis Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Oligonucleotide Synthesis Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Oligonucleotide Synthesis Market Size (2016-2027)
    9.2 Latin America Oligonucleotide Synthesis Market Size by Type
        9.2.1 Latin America Oligonucleotide Synthesis Market Size by Type (2016-2021)
        9.2.2 Latin America Oligonucleotide Synthesis Market Size by Type (2022-2027)
        9.2.3 Latin America Oligonucleotide Synthesis Market Size by Type (2016-2027)
    9.3 Latin America Oligonucleotide Synthesis Market Size by End User
        9.3.1 Latin America Oligonucleotide Synthesis Market Size by End User (2016-2021)
        9.3.2 Latin America Oligonucleotide Synthesis Market Size by End User (2022-2027)
        9.3.3 Latin America Oligonucleotide Synthesis Market Size by End User (2016-2027)
    9.4 Latin America Oligonucleotide Synthesis Market Size by Country
        9.4.1 Latin America Oligonucleotide Synthesis Market Size by Country (2016-2021)
        9.4.2 Latin America Oligonucleotide Synthesis Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Oligonucleotide Synthesis Market Size (2016-2027)
    10.2 Middle East & Africa Oligonucleotide Synthesis Market Size by Type
        10.2.1 Middle East & Africa Oligonucleotide Synthesis Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Oligonucleotide Synthesis Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Oligonucleotide Synthesis Market Size by Type (2016-2027)
    10.3 Middle East & Africa Oligonucleotide Synthesis Market Size by End User
        10.3.1 Middle East & Africa Oligonucleotide Synthesis Market Size by End User (2016-2021)
        10.3.2 Middle East & Africa Oligonucleotide Synthesis Market Size by End User (2022-2027)
        10.3.3 Middle East & Africa Oligonucleotide Synthesis Market Size by End User (2016-2027)
    10.4 Middle East & Africa Oligonucleotide Synthesis Market Size by Country
        10.4.1 Middle East & Africa Oligonucleotide Synthesis Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Oligonucleotide Synthesis Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Integrated DNA Technologies
        11.1.1 Integrated DNA Technologies Company Details
        11.1.2 Integrated DNA Technologies Business Overview
        11.1.3 Integrated DNA Technologies Oligonucleotide Synthesis Introduction
        11.1.4 Integrated DNA Technologies Revenue in Oligonucleotide Synthesis Business (2016-2021)
        11.1.5 Integrated DNA Technologies Recent Development
    11.2 Merck
        11.2.1 Merck Company Details
        11.2.2 Merck Business Overview
        11.2.3 Merck Oligonucleotide Synthesis Introduction
        11.2.4 Merck Revenue in Oligonucleotide Synthesis Business (2016-2021)
        11.2.5 Merck Recent Development
    11.3 Eurofins Genomics
        11.3.1 Eurofins Genomics Company Details
        11.3.2 Eurofins Genomics Business Overview
        11.3.3 Eurofins Genomics Oligonucleotide Synthesis Introduction
        11.3.4 Eurofins Genomics Revenue in Oligonucleotide Synthesis Business (2016-2021)
        11.3.5 Eurofins Genomics Recent Development
    11.4 Thermo Fisher Scientific
        11.4.1 Thermo Fisher Scientific Company Details
        11.4.2 Thermo Fisher Scientific Business Overview
        11.4.3 Thermo Fisher Scientific Oligonucleotide Synthesis Introduction
        11.4.4 Thermo Fisher Scientific Revenue in Oligonucleotide Synthesis Business (2016-2021)
        11.4.5 Thermo Fisher Scientific Recent Development
    11.5 Agilent Technologies
        11.5.1 Agilent Technologies Company Details
        11.5.2 Agilent Technologies Business Overview
        11.5.3 Agilent Technologies Oligonucleotide Synthesis Introduction
        11.5.4 Agilent Technologies Revenue in Oligonucleotide Synthesis Business (2016-2021)
        11.5.5 Agilent Technologies Recent Development
    11.6 Eurogentec
        11.6.1 Eurogentec Company Details
        11.6.2 Eurogentec Business Overview
        11.6.3 Eurogentec Oligonucleotide Synthesis Introduction
        11.6.4 Eurogentec Revenue in Oligonucleotide Synthesis Business (2016-2021)
        11.6.5 Eurogentec Recent Development
    11.7 GE Healthcare
        11.7.1 GE Healthcare Company Details
        11.7.2 GE Healthcare Business Overview
        11.7.3 GE Healthcare Oligonucleotide Synthesis Introduction
        11.7.4 GE Healthcare Revenue in Oligonucleotide Synthesis Business (2016-2021)
        11.7.5 GE Healthcare Recent Development
    11.8 LGC Biosearch Technologies
        11.8.1 LGC Biosearch Technologies Company Details
        11.8.2 LGC Biosearch Technologies Business Overview
        11.8.3 LGC Biosearch Technologies Oligonucleotide Synthesis Introduction
        11.8.4 LGC Biosearch Technologies Revenue in Oligonucleotide Synthesis Business (2016-2021)
        11.8.5 LGC Biosearch Technologies Recent Development
    11.9 Nitto Denko Avecia
        11.9.1 Nitto Denko Avecia Company Details
        11.9.2 Nitto Denko Avecia Business Overview
        11.9.3 Nitto Denko Avecia Oligonucleotide Synthesis Introduction
        11.9.4 Nitto Denko Avecia Revenue in Oligonucleotide Synthesis Business (2016-2021)
        11.9.5 Nitto Denko Avecia Recent Development
    11.10 Genscript
        11.10.1 Genscript Company Details
        11.10.2 Genscript Business Overview
        11.10.3 Genscript Oligonucleotide Synthesis Introduction
        11.10.4 Genscript Revenue in Oligonucleotide Synthesis Business (2016-2021)
        11.10.5 Genscript Recent Development
    11.11 Genedesign
        11.11.1 Genedesign Company Details
        11.11.2 Genedesign Business Overview
        11.11.3 Genedesign Oligonucleotide Synthesis Introduction
        11.11.4 Genedesign Revenue in Oligonucleotide Synthesis Business (2016-2021)
        11.11.5 Genedesign Recent Development
    11.12 TriLink Biotechnologies
        11.12.1 TriLink Biotechnologies Company Details
        11.12.2 TriLink Biotechnologies Business Overview
        11.12.3 TriLink Biotechnologies Oligonucleotide Synthesis Introduction
        11.12.4 TriLink Biotechnologies Revenue in Oligonucleotide Synthesis Business (2016-2021)
        11.12.5 TriLink Biotechnologies Recent Development
    11.13 Bio-Synthesis
        11.13.1 Bio-Synthesis Company Details
        11.13.2 Bio-Synthesis Business Overview
        11.13.3 Bio-Synthesis Oligonucleotide Synthesis Introduction
        11.13.4 Bio-Synthesis Revenue in Oligonucleotide Synthesis Business (2016-2021)
        11.13.5 Bio-Synthesis Recent Development
    11.14 ATDBio
        11.14.1 ATDBio Company Details
        11.14.2 ATDBio Business Overview
        11.14.3 ATDBio Oligonucleotide Synthesis Introduction
        11.14.4 ATDBio Revenue in Oligonucleotide Synthesis Business (2016-2021)
        11.14.5 ATDBio Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Oligonucleotide Synthesis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Custom Oligonucleotides
    Table 3. Key Players of Pre-designed Oligonucleotides
    Table 4. Global Oligonucleotide Synthesis Market Size Growth by End User (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Oligonucleotide Synthesis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Oligonucleotide Synthesis Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Oligonucleotide Synthesis Market Share by Regions (2016-2021)
    Table 8. Global Oligonucleotide Synthesis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Oligonucleotide Synthesis Market Share by Regions (2022-2027)
    Table 10. Oligonucleotide Synthesis Market Trends
    Table 11. Oligonucleotide Synthesis Market Drivers
    Table 12. Oligonucleotide Synthesis Market Challenges
    Table 13. Oligonucleotide Synthesis Market Restraints
    Table 14. Global Oligonucleotide Synthesis Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Oligonucleotide Synthesis Market Share by Players (2016-2021)
    Table 16. Global Top Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotide Synthesis as of 2020)
    Table 17. Ranking of Global Top Oligonucleotide Synthesis Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Oligonucleotide Synthesis Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Oligonucleotide Synthesis Product Solution and Service
    Table 21. Date of Enter into Oligonucleotide Synthesis Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Oligonucleotide Synthesis Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Oligonucleotide Synthesis Revenue Market Share by Type (2016-2021)
    Table 25. Global Oligonucleotide Synthesis Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Oligonucleotide Synthesis Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Oligonucleotide Synthesis Market Size Share by End User (2016-2021) & (US$ Million)
    Table 28. Global Oligonucleotide Synthesis Revenue Market Share by End User (2016-2021)
    Table 29. Global Oligonucleotide Synthesis Forecasted Market Size by End User (2022-2027) (US$ Million)
    Table 30. Global Oligonucleotide Synthesis Revenue Market Share by End User (2022-2027) & (US$ Million)
    Table 31. North America Oligonucleotide Synthesis Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Oligonucleotide Synthesis Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Oligonucleotide Synthesis Market Size by End User (2016-2021) (US$ Million)
    Table 34. North America Oligonucleotide Synthesis Market Size by End User (2022-2027) & (US$ Million)
    Table 35. North America Oligonucleotide Synthesis Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Oligonucleotide Synthesis Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Oligonucleotide Synthesis Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Oligonucleotide Synthesis Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Oligonucleotide Synthesis Market Size by End User (2016-2021) (US$ Million)
    Table 40. Europe Oligonucleotide Synthesis Market Size by End User (2022-2027) & (US$ Million)
    Table 41. Europe Oligonucleotide Synthesis Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Oligonucleotide Synthesis Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Oligonucleotide Synthesis Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Oligonucleotide Synthesis Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Oligonucleotide Synthesis Market Size by End User (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Oligonucleotide Synthesis Market Size by End User (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Oligonucleotide Synthesis Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Oligonucleotide Synthesis Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Oligonucleotide Synthesis Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Oligonucleotide Synthesis Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Oligonucleotide Synthesis Market Size by End User (2016-2021) (US$ Million)
    Table 52. Latin America Oligonucleotide Synthesis Market Size by End User (2022-2027) & (US$ Million)
    Table 53. Latin America Oligonucleotide Synthesis Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Oligonucleotide Synthesis Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Oligonucleotide Synthesis Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Oligonucleotide Synthesis Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Oligonucleotide Synthesis Market Size by End User (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Oligonucleotide Synthesis Market Size by End User (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Oligonucleotide Synthesis Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Oligonucleotide Synthesis Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Integrated DNA Technologies Company Details
    Table 62. Integrated DNA Technologies Business Overview
    Table 63. Integrated DNA Technologies Oligonucleotide Synthesis Product
    Table 64. Integrated DNA Technologies Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
    Table 65. Integrated DNA Technologies Recent Development
    Table 66. Merck Company Details
    Table 67. Merck Business Overview
    Table 68. Merck Oligonucleotide Synthesis Product
    Table 69. Merck Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
    Table 70. Merck Recent Development
    Table 71. Eurofins Genomics Company Details
    Table 72. Eurofins Genomics Business Overview
    Table 73. Eurofins Genomics Oligonucleotide Synthesis Product
    Table 74. Eurofins Genomics Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
    Table 75. Eurofins Genomics Recent Development
    Table 76. Thermo Fisher Scientific Company Details
    Table 77. Thermo Fisher Scientific Business Overview
    Table 78. Thermo Fisher Scientific Oligonucleotide Synthesis Product
    Table 79. Thermo Fisher Scientific Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
    Table 80. Thermo Fisher Scientific Recent Development
    Table 81. Agilent Technologies Company Details
    Table 82. Agilent Technologies Business Overview
    Table 83. Agilent Technologies Oligonucleotide Synthesis Product
    Table 84. Agilent Technologies Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
    Table 85. Agilent Technologies Recent Development
    Table 86. Eurogentec Company Details
    Table 87. Eurogentec Business Overview
    Table 88. Eurogentec Oligonucleotide Synthesis Product
    Table 89. Eurogentec Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
    Table 90. Eurogentec Recent Development
    Table 91. GE Healthcare Company Details
    Table 92. GE Healthcare Business Overview
    Table 93. GE Healthcare Oligonucleotide Synthesis Product
    Table 94. GE Healthcare Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
    Table 95. GE Healthcare Recent Development
    Table 96. LGC Biosearch Technologies Company Details
    Table 97. LGC Biosearch Technologies Business Overview
    Table 98. LGC Biosearch Technologies Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
    Table 99. LGC Biosearch Technologies Recent Development
    Table 100. Nitto Denko Avecia Company Details
    Table 101. Nitto Denko Avecia Business Overview
    Table 102. Nitto Denko Avecia Oligonucleotide Synthesis Product
    Table 103. Nitto Denko Avecia Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
    Table 104. Nitto Denko Avecia Recent Development
    Table 105. Genscript Company Details
    Table 106. Genscript Business Overview
    Table 107. Genscript Oligonucleotide Synthesis Product
    Table 108. Genscript Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
    Table 109. Genscript Recent Development
    Table 110. Genedesign Company Details
    Table 111. Genedesign Business Overview
    Table 112. Genedesign Oligonucleotide Synthesis Product
    Table 113. Genedesign Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
    Table 114. Genedesign Recent Development
    Table 115. TriLink Biotechnologies Company Details
    Table 116. TriLink Biotechnologies Business Overview
    Table 117. TriLink Biotechnologies Oligonucleotide Synthesis Product
    Table 118. TriLink Biotechnologies Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
    Table 119. TriLink Biotechnologies Recent Development
    Table 120. Bio-Synthesis Company Details
    Table 121. Bio-Synthesis Business Overview
    Table 122. Bio-Synthesis Oligonucleotide Synthesis Product
    Table 123. Bio-Synthesis Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
    Table 124. Bio-Synthesis Recent Development
    Table 125. ATDBio Company Details
    Table 126. ATDBio Business Overview
    Table 127. ATDBio Oligonucleotide Synthesis Product
    Table 128. ATDBio Revenue in Oligonucleotide Synthesis Business (2016-2021) & (US$ Million)
    Table 129. ATDBio Recent Development
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oligonucleotide Synthesis Market Share by Type: 2020 VS 2027
    Figure 2. Custom Oligonucleotides Features
    Figure 3. Pre-designed Oligonucleotides Features
    Figure 4. Global Oligonucleotide Synthesis Market Share by End User: 2020 VS 2027
    Figure 5. Academic Research Institutes Case Studies
    Figure 6. Pharmaceutical and Biotechnology Companies Case Studies
    Figure 7. Diagnostic Laboratories Case Studies
    Figure 8. Others Case Studies
    Figure 9. Oligonucleotide Synthesis Report Years Considered
    Figure 10. Global Oligonucleotide Synthesis Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Oligonucleotide Synthesis Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Oligonucleotide Synthesis Market Share by Regions: 2020 VS 2027
    Figure 13. Global Oligonucleotide Synthesis Market Share by Regions (2022-2027)
    Figure 14. Global Oligonucleotide Synthesis Market Share by Players in 2020
    Figure 15. Global Top Oligonucleotide Synthesis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oligonucleotide Synthesis as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Oligonucleotide Synthesis Revenue in 2020
    Figure 17. Global Oligonucleotide Synthesis Revenue Market Share by Type (2016-2021)
    Figure 18. Global Oligonucleotide Synthesis Revenue Market Share by Type (2022-2027)
    Figure 19. North America Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Oligonucleotide Synthesis Market Share by Type (2016-2027)
    Figure 21. North America Oligonucleotide Synthesis Market Share by End User (2016-2027)
    Figure 22. North America Oligonucleotide Synthesis Market Share by Country (2016-2027)
    Figure 23. United States Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Oligonucleotide Synthesis Market Share by Type (2016-2027)
    Figure 27. Europe Oligonucleotide Synthesis Market Share by End User (2016-2027)
    Figure 28. Europe Oligonucleotide Synthesis Market Share by Country (2016-2027)
    Figure 29. Germany Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Oligonucleotide Synthesis Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Oligonucleotide Synthesis Market Share by End User (2016-2027)
    Figure 38. Asia-Pacific Oligonucleotide Synthesis Market Share by Region (2016-2027)
    Figure 39. China Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Oligonucleotide Synthesis Market Share by Type (2016-2027)
    Figure 47. Latin America Oligonucleotide Synthesis Market Share by End User (2016-2027)
    Figure 48. Latin America Oligonucleotide Synthesis Market Share by Country (2016-2027)
    Figure 49. Mexico Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Oligonucleotide Synthesis Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Oligonucleotide Synthesis Market Share by End User (2016-2027)
    Figure 54. Middle East & Africa Oligonucleotide Synthesis Market Share by Country (2016-2027)
    Figure 55. Turkey Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Oligonucleotide Synthesis Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Integrated DNA Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
    Figure 59. Merck Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
    Figure 60. Eurofins Genomics Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
    Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
    Figure 62. Agilent Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
    Figure 63. Eurogentec Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
    Figure 64. GE Healthcare Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
    Figure 65. LGC Biosearch Technologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
    Figure 66. Nitto Denko Avecia Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
    Figure 67. Genscript Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
    Figure 68. Genedesign Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
    Figure 69. TriLink Biotechnologies Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
    Figure 70. Bio-Synthesis Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
    Figure 71. ATDBio Revenue Growth Rate in Oligonucleotide Synthesis Business (2016-2021)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Integrated DNA Technologies
Merck
Eurofins Genomics
Thermo Fisher Scientific
Agilent Technologies
Eurogentec
GE Healthcare
LGC Biosearch Technologies
Nitto Denko Avecia
Genscript
Genedesign
TriLink Biotechnologies
Bio-Synthesis
ATDBio
Frequently Asked Questions
Oligonucleotide Synthesis report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oligonucleotide Synthesis report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oligonucleotide Synthesis report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Oncology Nutrition

Cancers are among the leading causes of morbidity and mortality worldwide, and the number of new  ... Read More

Online Advertising

Online advertising, also called online marketing or Internet advertising or web advertising, is a ... Read More

Open Source Services

Open-source software(OSS) is a type of computer softwarewhosesource codeis released under alicen ... Read More